Certara, Inc. (NASDAQ:CERT) Given Consensus Rating of “Hold” by Brokerages
Certara, Inc. (NASDAQ:CERT – Get Free Report) has been given an average rating of “Hold” by the thirteen brokerages that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has given a […]
JonesTrading Reiterates Hold Rating for Elicio Therapeutics (NASDAQ:ELTX)
Elicio Therapeutics (NASDAQ:ELTX – Get Free Report)‘s stock had its “hold” rating restated by analysts at JonesTrading in a report released on Tuesday,Benzinga reports. A number of other research firms have also recently weighed in on ELTX. Rodman & Renshaw reaffirmed a “buy” rating on shares of Elicio Therapeutics in a research report on Monday. […]
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of “Hold” by Brokerages
Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) have earned a consensus rating of “Hold” from the five analysts that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the […]
Heartland Express, Inc. (NASDAQ:HTLD) Given Consensus Rating of “Reduce” by Brokerages
Heartland Express, Inc. (NASDAQ:HTLD – Get Free Report) has been given a consensus rating of “Reduce” by the seven research firms that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the […]
i3 Verticals, Inc. (NASDAQ:IIIV) Given Consensus Rating of “Moderate Buy” by Brokerages
i3 Verticals, Inc. (NASDAQ:IIIV – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price […]
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a buy rating and one has assigned […]
last updated on 17 Jun 10:03